Vaginal Diseases

01/01/1984 - "This approach incorporates radium needles implant to the vaginal disease in conjunction with the usual routine intracavitary radium application. "
04/15/1988 - "Whole-pelvic irradiation, intracavity radium, and hysterectomy are effective treatment for occult pelvic and vaginal disease."

08/01/2015 - "Here we report the efficacy of a combination vaccine containing gC2/gD2 and UL19/UL47 for prevention of genital disease, vaginal shedding of HSV-2 DNA, and latent infection of dorsal root ganglia in guinea pigs."
04/01/2012 - "Immunized animals had reduced vaginal disease, vaginal titers, DRG infection, recurrent genital lesions, and recurrent vaginal shedding of HSV-2 DNA; however, protection was incomplete. "

03/01/1980 - "Experimental clinical study of 400 cases of vaginal diseases treated with the combination of amphotericin B and tetracycline]."

03/01/1980 - "Experimental clinical study of 400 cases of vaginal diseases treated with the combination of amphotericin B and tetracycline]."

01/01/2015 - "Vaginal small interfering RNA (siRNA) delivery provides a promising strategy for the prevention and treatment of vaginal diseases. "

12/31/1973 - "[Nifuratel in the treatment of vulvo-vaginal diseases in childhood]."

01/01/2012 - "Ibuprofen-isob may be considered a useful and effective tool for the topical treatment of nonspecific vaginal diseases."

01/01/2011 - "Topical administration of E3 for treatment of vaginal diseases is generally preferred, as this route of application of hormones produces a more significant local proliferative response and has no stimulating effect on the endometrium. "

04/01/2000 - "Exogenous acbvities on vaginal pH can be exerted by several factors, such as sexual activily, oral contraceptives, systemic diseases, vaginal infections (candidosis, thrichomonias, vaginosis), systemic or local therapies. "

06/01/1989 - "Flunoxaprofen may be considered a useful and active tool for the topical treatment of non specific vaginal diseases."

12/01/2015 - "For benign gynaecological disease, vaginal (VH) or laparoscopic (LH) hysterectomy are recommended (grade B). "
07/01/1992 - "This technique of partial colpectomy is an effective procedure, associated with minimal morbidity which should be considered as primary treatment for patients suffering from persistent vaginal disease after hysterectomy or other procedures."
10/01/1999 - "Primary surgical treatment consisting of abdominal hysterectomy and unilateral salpingo-oophorectomy was followed by multiple resections of recurrent vaginal disease. "
03/27/1996 - "Criteria for assessing risk of vaginal dysplasia or carcinoma included original research, documented reports of hysterectomy as an exposure, and evidence of preinvasive vaginal disease or vaginal carcinoma outcomes. "
04/15/1988 - "Whole-pelvic irradiation, intracavity radium, and hysterectomy are effective treatment for occult pelvic and vaginal disease."

09/27/2013 - "This review summarises the challenges and potential uses of nanodelivery system for the topical drug therapy of vaginal diseases. "
12/01/1996 - "Despite perioperative chemotherapy, lymph node metastasis was present in 36% of patients, parametrial disease in 38%, and vaginal disease in 45%. "
07/01/1991 - "Three patients with vaginal rhabdomyosarcoma and residual vaginal disease following surgery and chemotherapy have been treated using high dose irradiation with vaginal moulds loaded with iridium-192. "

02/01/2015 - "The prognosis and vaginal disease control rate after treatment with radiotherapy or concurrent chemoradiotherapy (CCRT) are reported to be worse for primary non-squamous cell carcinoma (non-SCC) of the vagina than for squamous cell carcinoma (SCC) of the vagina. "
10/01/2006 - "Between 1998 and 2004, 16 previously unirradiated patients with locally advanced cervical and vaginal cancer not suitable for intracavitary brachytherapy because of distorted anatomy or extensive vaginal disease were treated with HDRB in combination with external beam radiotherapy. "

10/01/1998 - "Even low doses of HDR brachytherapy seem sufficient for excellent vaginal disease control in moderate-risk disease. "
10/01/2006 - "Between 1998 and 2004, 16 previously unirradiated patients with locally advanced cervical and vaginal cancer not suitable for intracavitary brachytherapy because of distorted anatomy or extensive vaginal disease were treated with HDRB in combination with external beam radiotherapy. "

10/01/1980 - "The chronology of vaginal disease that appeared after treatment of cervical neoplasia suggests a persistent but decreasing likelihood of the development of VAIN with the passage of time. "
02/01/2015 - "The prognosis and vaginal disease control rate after treatment with radiotherapy or concurrent chemoradiotherapy (CCRT) are reported to be worse for primary non-squamous cell carcinoma (non-SCC) of the vagina than for squamous cell carcinoma (SCC) of the vagina. "